Global Neonate Bilirubin Phototherapy Equipment Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Neonate Bilirubin Phototherapy Equipment market size was valued at US$ 263 million in 2024 and is forecast to a readjusted size of USD 317 million by 2031 with a CAGR of 2.7% during review period.
Jaundice (Hyperbilirubinemia) is a common condition, particularly in pre-mature babies worldwide. The skin of the newborn baby becomes jaundiced (baby’s skin and Sclerae appear yellow) which is caused by a high level of bilirubin in the blood. Bilirubin is a waste product, produced when red blood cells are broken down. It is normally broken down in the liver and removed from the body in the stool. However, an underdeveloped liver of infant cannot filter out the bilirubin as fast as it i being produced, resulting in hyperbilirubinemia (Jaundice). If untreated the levels of bilirubin may rise high enough to pass through the blood brain barrier and is deposited in the brain causing Kernicterus and brain damage. Phototherapy is a treatment with special type of light (wavelength range 420 to 480nm) which lower bilirubin level in neonatal, the process is called photo-oxidation in which light wave converts the bilirubin to water soluble non-toxic form, make it easier for baby’s liver to break down and remove the bilirubin from their blood.
The market driver for Neonate Bilirubin Phototherapy Equipment is the increasing prevalence of neonatal jaundice and the growing awareness of the importance of early and effective treatment to manage this condition. Neonate Bilirubin Phototherapy Equipment is specialized medical equipment used to treat neonatal jaundice, a common condition in newborn babies caused by the accumulation of bilirubin in the blood. Several factors contribute to the growing demand for Neonate Bilirubin Phototherapy Equipment in the market:
Prevalence of Neonatal Jaundice: Neonatal jaundice is one of the most common medical conditions in newborns, affecting a significant number of infants worldwide.
Impact on Neonatal Health: Untreated or poorly managed neonatal jaundice can lead to serious complications, including kernicterus and neurological damage. Phototherapy is an effective treatment to prevent these complications.
Non-Invasive Treatment: Bilirubin phototherapy is a non-invasive treatment that reduces the need for more invasive procedures, such as blood transfusions, in neonates with jaundice.
Medical Advancements and Technology: Advances in medical technology and phototherapy equipment design have improved the efficiency and effectiveness of neonate bilirubin phototherapy.
Rising Awareness: Increased awareness among healthcare providers and parents about the importance of early diagnosis and treatment of neonatal jaundice drives the demand for phototherapy equipment.
Improved Neonatal Care Facilities: Expanding neonatal care facilities, particularly in developing regions, create a higher demand for neonate bilirubin phototherapy equipment.
Government Initiatives: Government initiatives and healthcare programs focusing on newborn health and well-being contribute to the adoption of neonate bilirubin phototherapy equipment.
Technological Advancements: Ongoing advancements in phototherapy technology, such as the development of LED-based phototherapy devices, drive the adoption of newer and more efficient equipment.
Hospital and NICU Investments: Hospitals and neonatal intensive care units (NICUs) invest in advanced neonate bilirubin phototherapy equipment to enhance the quality of neonatal care.
Growing Preterm Births: Preterm infants are more susceptible to neonatal jaundice, leading to an increased demand for neonate bilirubin phototherapy equipment.
This report is a detailed and comprehensive analysis for global Neonate Bilirubin Phototherapy Equipment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neonate Bilirubin Phototherapy Equipment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Neonate Bilirubin Phototherapy Equipment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Neonate Bilirubin Phototherapy Equipment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Neonate Bilirubin Phototherapy Equipment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neonate Bilirubin Phototherapy Equipment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neonate Bilirubin Phototherapy Equipment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare, Weyer GmbH, Delta Medical International, Natus Medical Incorporated, Medicor, Drager, Zeal Medical, MTTS, David Medical Device, BEING MEDICAL DEVICE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Neonate Bilirubin Phototherapy Equipment market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Contact Type
Contactless Type
Market segment by Application
Hospitals
Confinement Centers
Others
Major players covered
GE Healthcare
Weyer GmbH
Delta Medical International
Natus Medical Incorporated
Medicor
Drager
Zeal Medical
MTTS
David Medical Device
BEING MEDICAL DEVICE
BIOBASE
Julongsanyou Technology
Phoenix Medical Systems
Ibis Medical
Apothecaries Sundries Manufacturing
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neonate Bilirubin Phototherapy Equipment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neonate Bilirubin Phototherapy Equipment, with price, sales quantity, revenue, and global market share of Neonate Bilirubin Phototherapy Equipment from 2020 to 2025.
Chapter 3, the Neonate Bilirubin Phototherapy Equipment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neonate Bilirubin Phototherapy Equipment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Neonate Bilirubin Phototherapy Equipment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neonate Bilirubin Phototherapy Equipment.
Chapter 14 and 15, to describe Neonate Bilirubin Phototherapy Equipment sales channel, distributors, customers, research findings and conclusion.
Jaundice (Hyperbilirubinemia) is a common condition, particularly in pre-mature babies worldwide. The skin of the newborn baby becomes jaundiced (baby’s skin and Sclerae appear yellow) which is caused by a high level of bilirubin in the blood. Bilirubin is a waste product, produced when red blood cells are broken down. It is normally broken down in the liver and removed from the body in the stool. However, an underdeveloped liver of infant cannot filter out the bilirubin as fast as it i being produced, resulting in hyperbilirubinemia (Jaundice). If untreated the levels of bilirubin may rise high enough to pass through the blood brain barrier and is deposited in the brain causing Kernicterus and brain damage. Phototherapy is a treatment with special type of light (wavelength range 420 to 480nm) which lower bilirubin level in neonatal, the process is called photo-oxidation in which light wave converts the bilirubin to water soluble non-toxic form, make it easier for baby’s liver to break down and remove the bilirubin from their blood.
The market driver for Neonate Bilirubin Phototherapy Equipment is the increasing prevalence of neonatal jaundice and the growing awareness of the importance of early and effective treatment to manage this condition. Neonate Bilirubin Phototherapy Equipment is specialized medical equipment used to treat neonatal jaundice, a common condition in newborn babies caused by the accumulation of bilirubin in the blood. Several factors contribute to the growing demand for Neonate Bilirubin Phototherapy Equipment in the market:
Prevalence of Neonatal Jaundice: Neonatal jaundice is one of the most common medical conditions in newborns, affecting a significant number of infants worldwide.
Impact on Neonatal Health: Untreated or poorly managed neonatal jaundice can lead to serious complications, including kernicterus and neurological damage. Phototherapy is an effective treatment to prevent these complications.
Non-Invasive Treatment: Bilirubin phototherapy is a non-invasive treatment that reduces the need for more invasive procedures, such as blood transfusions, in neonates with jaundice.
Medical Advancements and Technology: Advances in medical technology and phototherapy equipment design have improved the efficiency and effectiveness of neonate bilirubin phototherapy.
Rising Awareness: Increased awareness among healthcare providers and parents about the importance of early diagnosis and treatment of neonatal jaundice drives the demand for phototherapy equipment.
Improved Neonatal Care Facilities: Expanding neonatal care facilities, particularly in developing regions, create a higher demand for neonate bilirubin phototherapy equipment.
Government Initiatives: Government initiatives and healthcare programs focusing on newborn health and well-being contribute to the adoption of neonate bilirubin phototherapy equipment.
Technological Advancements: Ongoing advancements in phototherapy technology, such as the development of LED-based phototherapy devices, drive the adoption of newer and more efficient equipment.
Hospital and NICU Investments: Hospitals and neonatal intensive care units (NICUs) invest in advanced neonate bilirubin phototherapy equipment to enhance the quality of neonatal care.
Growing Preterm Births: Preterm infants are more susceptible to neonatal jaundice, leading to an increased demand for neonate bilirubin phototherapy equipment.
This report is a detailed and comprehensive analysis for global Neonate Bilirubin Phototherapy Equipment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neonate Bilirubin Phototherapy Equipment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Neonate Bilirubin Phototherapy Equipment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Neonate Bilirubin Phototherapy Equipment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Neonate Bilirubin Phototherapy Equipment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neonate Bilirubin Phototherapy Equipment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neonate Bilirubin Phototherapy Equipment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare, Weyer GmbH, Delta Medical International, Natus Medical Incorporated, Medicor, Drager, Zeal Medical, MTTS, David Medical Device, BEING MEDICAL DEVICE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Neonate Bilirubin Phototherapy Equipment market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Contact Type
Contactless Type
Market segment by Application
Hospitals
Confinement Centers
Others
Major players covered
GE Healthcare
Weyer GmbH
Delta Medical International
Natus Medical Incorporated
Medicor
Drager
Zeal Medical
MTTS
David Medical Device
BEING MEDICAL DEVICE
BIOBASE
Julongsanyou Technology
Phoenix Medical Systems
Ibis Medical
Apothecaries Sundries Manufacturing
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neonate Bilirubin Phototherapy Equipment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neonate Bilirubin Phototherapy Equipment, with price, sales quantity, revenue, and global market share of Neonate Bilirubin Phototherapy Equipment from 2020 to 2025.
Chapter 3, the Neonate Bilirubin Phototherapy Equipment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neonate Bilirubin Phototherapy Equipment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Neonate Bilirubin Phototherapy Equipment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neonate Bilirubin Phototherapy Equipment.
Chapter 14 and 15, to describe Neonate Bilirubin Phototherapy Equipment sales channel, distributors, customers, research findings and conclusion.
Table of Contents
107 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Neonate Bilirubin Phototherapy Equipment by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
